STATE STREET CORP - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 47 filers reported holding PLX PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PLX PHARMA INC
ValueSharesWeighting
Q1 2023$10,295
-60.4%
79,132
-50.0%
0.00%
Q4 2022$25,972
-49.1%
158,264
+100.0%
0.00%
Q3 2022$51,000
-73.4%
79,1320.0%0.00%
Q2 2022$192,000
-40.0%
79,1320.0%0.00%
Q1 2022$320,000
-46.7%
79,132
+5.6%
0.00%
Q4 2021$600,000
-58.3%
74,940
+0.5%
0.00%
Q3 2021$1,439,000
+46.5%
74,540
+4.8%
0.00%
Q2 2021$982,00071,1400.00%
Other shareholders
PLX PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
MSD Partners, L.P. 1,875,000$4,556,0000.28%
Ground Swell Capital, LLC 48,931$119,0000.22%
Park West Asset Management LLC 1,473,218$3,580,0000.20%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$152,0000.07%
Eidelman Virant Capital 27,000$63,0000.04%
MBL Wealth, LLC 52,000$1260.03%
O'Brien Greene & Co. Inc 22,340$54,0000.02%
SHUFRO ROSE & CO LLC 56,800$138,0000.01%
GW&K Investment Management, LLC 424,921$1,033,0000.01%
EXANE DERIVATIVES 6,575$15,974,0000.01%
View complete list of PLX PHARMA INC shareholders